Adrian Murphy
Impact in
Papers in
- Oncology 45
- Cancer Immunotherapy and Biomarkers 18
- Pancreatic and Hepatic Oncology Research 12
- Colorectal Cancer Treatments and Studies 7
- Peptidase Inhibition and Analysis 5
- Co-authors
- Lei ZhengArsen OsipovDaniel V.T. CatenacciDo‐Youn OhMitesh J. BoradGhassan K. Abou‐AlfaAntoine HollebecqueGina M. Vaccaro
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (5 papers)Cancer Research (4 papers)Clinical Epigenetics (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
Adrian Murphy
55 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.6k
- Surgery 1.2k
- Cancer Research 390
- Pulmonary and Respiratory Medicine 785
- Immunology 469
Countries citing papers authored by Adrian Murphy
This map shows the geographic impact of Adrian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Murphy more than expected).
Fields of papers citing papers by Adrian Murphy
This network shows the impact of papers produced by Adrian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Murphy. The network helps show where Adrian Murphy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adrian Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 16 | |
| 4 | 2023 | 12 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 49 | |
| 7 | 2021 | 1 | |
| 8 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Hit paper breakdown → | 2020 | 975 |
| 9 | 2019 | 68 | |
| 10 | 2019 | 57 | |
| 11 | 2019 | 16 | |
| 12 | 2019 | 52 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 92 | |
| 16 | Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma Hit paper breakdown → | 2016 | 359 |
| 17 | 2016 | 16 | |
| 18 | 2016 | 44 | |
| 19 | 2015 | 26 | |
| 20 | 2015 | 8 |
About Adrian Murphy
Adrian Murphy is a scholar working on Oncology, Biological Psychiatry, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Pancreatic and Hepatic Oncology Research (12 papers), Fibroblast Growth Factor Research (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Peptidase Inhibition and Analysis (5 papers), Immunotherapy and Immune Responses (5 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (1.6k citations), Surgery (1.2k citations), Cancer Research (390 citations), Pulmonary and Respiratory Medicine (785 citations) and Immunology (469 citations). Adrian Murphy has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Lei Zheng, Arsen Osipov, Daniel V.T. Catenacci, Do‐Youn Oh, Mitesh J. Borad, Ghassan K. Abou‐Alfa, Antoine Hollebecque, Gina M. Vaccaro, Christine Lihou and Andrew Scott Paulson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Epigenetics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.